Advertisement
Screener

OUTLOOK THERAPEUTICS, INC. (OTLK) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

OUTLOOK THERAPEUTICS, INC. (OTLK) Return on Tangible Equity

  • 2026-06-30: Return Tang Equity 588.14%.
  • 2026-03-31: Return Tang Equity 210.23%.
  • 2025-12-31: Return Tang Equity 266.83%.
  • 2025-09-30: Return Tang Equity 193.94%.

Complete source-backed return tang equity history.

Available history
2015-09-30 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang Equity
2026-06-30588.14%
2026-03-31210.23%
2025-12-31266.83%
2025-09-30193.94%
2025-06-30116.81%
2025-03-31-65.06%
2024-12-3193.08%
2024-09-30103.13%
2024-06-30112.40%
2024-03-31118.55%
2023-12-31211.55%
2023-09-30408.53%
2023-06-301096.47%
2023-03-31-545.42%
2022-12-31-445.80%
2022-09-30-756.04%
2022-06-30-324.23%
2022-03-31-166.20%
2021-12-31-108.90%
2021-09-30-1153.86%
2021-06-30-389.68%
2021-03-31-196.11%
2020-12-31315.92%
2020-09-30-1246.85%
2020-06-30-322.96%
2020-03-31179.49%
2019-12-31133.79%
2019-09-30214.04%
2019-06-30558.72%
2019-03-31144.62%
2018-12-31143.86%
2018-09-30117.80%
2018-06-30183.84%
2018-03-3163.06%
2017-12-3186.38%
2017-09-30115.45%
2017-06-30148.73%
2017-03-31223.58%
2016-12-31254.38%
2016-09-301030.41%
2016-06-30-3831.96%
2016-03-31129.17%

Annual Return Tang Equity

DateReturn Tang Equity
2025-09-30193.94%
2024-09-30103.13%
2023-09-30408.53%
2022-09-30-756.04%
2021-09-30-1153.86%
2020-09-30-1246.85%
2019-09-30214.04%
2018-09-30117.80%
2017-09-30115.45%
2016-09-301030.41%
2015-09-3087.41%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48